DiaMedica Therapeutics (DMAC) Other Non Operating Income (2018 - 2026)

DiaMedica Therapeutics (DMAC) has reported Other Non Operating Income for 9 consecutive years, with $366000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non Operating Income rose 16.56% year-over-year to $366000.0; the trailing twelve-month figure through Jun 2026 stood at $2.5 million (down 18.71% YoY), and the FY2025 full-year result was $1.7 million, down 26.82% from the prior year.
• Other Non Operating Income fell to $366000.0 in Q2 2026 per DMAC's latest filing, from $447000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $2.3 million in Q4 2024 and bottomed at -$21000.0 in Q3 2025.
• Historically, Other Non Operating Income has averaged $466333.3 across 5 years, with a median of $292500.0 in 2023.
• The widest YoY moves for Other Non Operating Income: up 15600.0% in 2025, down 950.0% in 2025.
• Over 5 years, Other Non Operating Income stood at $229000.0 in 2022, then surged by 209.61% to $709000.0 in 2023, then jumped by 222.43% to $2.3 million in 2024, then slipped by 26.51% to $1.7 million in 2025, then sank by 78.21% to $366000.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $366000.0, $447000.0, and $1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.